Isolation of T-Cell Receptors Specifically Reactive with Mutated Tumor-Associated Antigens from Tumor-Infiltrating Lymphocytes Based on CD137 Expression

CD137 生物 T细胞受体 T细胞 过继性细胞移植 分子生物学 CD8型 抗原 癌症研究 免疫学 免疫系统
作者
Maria R. Parkhurst,Alena Gros,Anna Pasetto,Todd D. Prickett,Jessica S. Crystal,Paul F. Robbins,Steven A. Rosenberg
出处
期刊:Clinical Cancer Research [American Association for Cancer Research]
卷期号:23 (10): 2491-2505 被引量:171
标识
DOI:10.1158/1078-0432.ccr-16-2680
摘要

Purpose: The adoptive transfer of lymphocytes genetically modified to express tumor reactive T-cell receptors (TCR) can mediate tumor regression. Some tumor-infiltrating lymphocytes (TIL) recognize somatic mutations expressed only in the patient's tumors, and evidence suggests that clinically effective TILs target tumor-specific neoantigens. Here we attempted to isolate neoantigen-reactive TCRs as a prelude to the treatment of patients with autologous T cells genetically modified to express such TCRs.Experimental Design: Mutations expressed by tumors were identified using whole-exome and RNA sequencing. Tandem minigene (TMG) constructs encoding 12-24 mutated gene products were synthesized, each encoding the mutated amino acid flanked by 12 amino acids of the normal protein sequence. TILs were cultured with autologous dendritic cells (DC) transfected with in vitro transcribed (IVT) mRNAs encoding TMGs and were evaluated for IFNγ secretion and CD137 expression. Neoantigen-reactive T cells were enriched from TILs by sorting for CD137+ CD8+ T cells and expanded in vitro Dominant TCR α and β chains were identified in the enriched populations using a combination of 5' rapid amplification of cDNA ends, deep sequencing of genomic DNA, PairSeq analysis, and single-cell RT-PCR analysis. Human PBL retrovirally transduced to express the TCRs were evaluated for recognition of relevant neoantigens.Results: We identified 27 TCRs from 6 patients that recognized 14 neoantigens expressed by autologous tumor cells.Conclusions: This strategy provides the means to generate T cells expressing neoantigen-reactive TCRs for use in future adoptive cell transfer immunotherapy trials for patients with cancer. Clin Cancer Res; 23(10); 2491-505. ©2016 AACR.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
陈攀发布了新的文献求助10
刚刚
在水一方的应助被苗条故事采纳,获得10
刚刚
1秒前
111发布了新的文献求助10
1秒前
研友_8QyXr8发布了新的文献求助10
1秒前
虎虎生风完成签到,获得积分10
2秒前
三分之二发布了新的文献求助50
3秒前
4秒前
4秒前
秋风的应助被仲阳采纳,获得10
4秒前
5秒前
6秒前
sunwei完成签到,获得积分10
6秒前
艾方十完成签到,获得积分10
6秒前
7秒前
7秒前
wqq2972完成签到,获得积分10
8秒前
李健的应助被科研通管家采纳,获得10
8秒前
Sheep的应助被科研通管家采纳,获得10
8秒前
田様的应助被科研通管家采纳,获得10
8秒前
ccq的应助被科研通管家采纳,获得10
8秒前
李健的应助被Hansky采纳,获得10
8秒前
科研通AI2S的应助被科研通管家采纳,获得10
8秒前
小二郎的应助被科研通管家采纳,获得10
8秒前
慕青的应助被科研通管家采纳,获得10
8秒前
null的应助被科研通管家采纳,获得10
8秒前
搜集达人的应助被科研通管家采纳,获得10
9秒前
小蘑菇的应助被科研通管家采纳,获得10
9秒前
赘婿的应助被科研通管家采纳,获得10
9秒前
情怀的应助被科研通管家采纳,获得10
9秒前
Maestro_S的应助被科研通管家采纳,获得10
9秒前
慕青的应助被科研通管家采纳,获得10
9秒前
李健的应助被激昂的如柏采纳,获得10
9秒前
9秒前
英俊的铭的应助被科研通管家采纳,获得10
9秒前
9秒前
慕青的应助被科研通管家采纳,获得10
10秒前
金光闪闪发布了新的文献求助10
10秒前
sagitar的应助被Superg采纳,获得60
10秒前
11秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8177767
求助须知:如何正确求助?哪些是违规求助? 9568590
关于积分的说明 21799821
捐赠科研通 7772374
什么是DOI,文献DOI怎么找? 3432476
关于科研通互助平台的介绍 2556695
邀请新用户注册赠送积分活动 2478034